Skip to content
Catalyst

PapersPMID:25474484

Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.

The Cochrane database of systematic reviews2014The record ↗

findings
4
compound
1
endpoints
4
PMID:25474484
  1. Finding, very limited evidenceno difference foundDiastolic blood pressure
  2. Finding, very limited evidenceno difference foundTotal cholesterol (TC)
  3. Finding, very limited evidenceno difference foundHDL cholesterol
  4. Finding, very limited evidenceno difference foundTriglycerides

No finding here moved its endpoint.

  • “For diastolic blood pressure we performed a random-effects meta-analysis, which showed no evidence of effect of CoQ10 supplementation when these two small trials were pooled (MD -1.62 mmHg, 95% CI -5.2 to 1.96).”
    Study
    meta-analysis
    Effect
    −1.62 mean difference, 95% CI −5.2 to 1.96
    Population
    adults at high risk of cardiovascular disease without a diagnosis of CVD; pooled analysis of two small RCTs
  • “The trial showed no evidence of effect of CoQ10 supplementation on total cholesterol (MD 0.30 mmol/L, 95% CI -0.10 to 0.70), high-density lipoprotein (HDL)-cholesterol (MD 0.02 mmol/L, 95% CI -0.13 to 0.17) or triglycerides (MD 0.05 mmol/L, 95% CI -0.42 to 0.52).”
    • Study
      RCT
      Effect
      0.3 mean difference, 95% CI −0.1 to 0.7
      Population
      adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)
    • No detected effect on HDL cholesterol

      very limitedreplicated ×3

      Study
      RCT
      Effect
      0.02 mean difference, 95% CI −0.13 to 0.17
      Population
      adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)
    • No detected effect on triglycerides

      very limitedreplicated ×2

      Study
      RCT
      Effect
      0.05 mean difference, 95% CI −0.42 to 0.52
      Population
      adults at high risk of cardiovascular disease without a diagnosis of CVD; single RCT (51 patients randomised)

Study record

Design
meta-analysis
Species
human
Population
healthy adults or those at high cardiovascular risk without a diagnosis of CVD; 6 RCTs, 218 participants total
Participants
218
Comparator
not stated in the paper
Duration
not reported
Endpoints measured
9